Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Biotechnology company InterMune has closed its public offering of 4.02 million shares of common stock at a price to the public of $19.50 per share, including 525,000 shares of common stock, representing the exercise by the underwriters of their option to purchase additional shares in the offering.
Subscribe to our email newsletter
The net proceeds to the company of the offering are approximately $73.8 million, after payment of underwriting discounts and commissions, but excluding estimated offering expenses.
Goldman, Sachs & Company acted as the sole book-running manager of the offering. Deutsche Bank Securities acted as co-lead manager and CIBC World Markets acted as co-manager of the offering. These shares were issued pursuant to an effective shelf registration statement.